TrialLeukemia2013
Phase II study of nilotinib in patients with relapsed or refractory Philadelphia chromosome--positive acute lymphoblastic leukemia.
O G Ottmann et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this papercites it